Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT |
| |
Authors: | F. Hemingway T.G. KashimaH.J. Knowles N.A. Athanasou |
| |
Affiliation: | Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Nuffield Orthopaedic Centre, Oxford, OX3 7HE, United Kingdom |
| |
Abstract: | LIGHT (TNFSF14) is a member of the TNF superfamily and is known to substitute for RANKL to induce osteoclast differentiation. LIGHT binds HVEM and LTβR, but it is not known whether these receptors play a role in osteoclast formation or whether LIGHT acts via RANKL signalling pathways. We found that both RANKL and LIGHT strongly induced phosphorylation of Akt and NFκB but not JNK in mouse osteoclast precursor cells. The addition of an Akt inhibitor showed decreased osteoclast differentiation and resorption mediated by both RANKL and LIGHT. RT-PCR and FACS analysis showed that CD14+ human osteoclast precursors expressed HVEM and LTβR; expression levels of HVEM increased in the course of osteoclastogenesis and a decrease in LIGHT expression was associated with an increase in HVEM suggesting that there is a feedback loop related to this receptor. Our findings show that LIGHT is not inhibited by the soluble RANKL receptor OPG and that LIGHT is a potent osteoclastogenesis factor that activates the Akt, NFκB and JNK pathways. |
| |
Keywords: | LIGHT, lymphotoxin exhibiting inducible expression and competing with herpes simplex virus glycoprotein D for herpesvirus entry mediator, a receptor expressed by T lymphocytes RANKL, receptor activator of NFκB ligand HVEM, herpesvirus entry mediator LTβR, lymphotoxin β receptor DcR3, decoy receptor 3 TRAF, TNF receptor-associated factor OPG, osteoprotegerin MCSF, macrophage colony-stimulating factor TNFα ?, tumour necrosis factor-alpha PBMCs, peripheral blood mononuclear cells |
本文献已被 ScienceDirect 等数据库收录! |
|